Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Neoplasma Vol.61, No.3, p.340-351, 2014 |
||
Title: Update meta-analysis on 1790G/A polymorphism and cancer risk: Evidence from 26 studies | ||
Author: P. LIU, H. SHI, Y. YANG, R. LIU, C. HUANG, H. SHU, J. LI, Q. CHEN, Y. YANG, M. CAI | ||
Abstract: The results from the published studies on the association between hypoxia-inducible factor-1(Hif-1/HIF-1) polymorphisms and cancer risk are conflicting. The common 1790G/A rs11549467) genetic polymorphism has been reported to be functional and may contribute to genetic susceptibility to cancers. However, the association between 1790G/A (rs11549467) and cancer risk remains inconclusive. We also observed that the AA genotype might modulate lung cancer (OR=5.42[2.75-10.70]), pancreatic cancer (OR=9.30[1.12-77.61]) and oral squamous cell carcinoma (OSCC) (OR=13.32[1.57-112.75]) risk comparing with the GG genotype. Moreover, a significantly increased cancer risk was found in homozygote comparison (AA vs. GG) and recessive genetic model (AA vs. AG/GG) among Caucasian population. When stratified by study design, significantly elevated susceptibility to cancer was found among hospital-based studies. |
||
Keywords: Hif-1/HIF-1, 1790G/A, cancer, genetic polymorphism, meta-analysis | ||
Published online: 31-Jan-2014 | ||
Year: 2014, Volume: 61, Issue: 3 | Page From: 340, Page To: 351 | |
doi:10.4149/neo_2014_044 |
||
|
download file |
|